Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Global Cancer Screening Technology Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Key Market Segments
  • 1.3 Players Covered: Ranking by Cancer Screening Technology Revenue
  • 1.4 Covid-19 Implications on Market by Type
    • 1.4.1 Global Cancer Screening Technology Market Size Growth Rate by Type: 2020 VS 2026
    • 1.4.2 Instrument-based Inspection
    • 1.4.3 Platform-based Inspection
  • 1.5 Market by Application
    • 1.5.1 Global Cancer Screening Technology Market Share by Application: 2020 VS 2026
    • 1.5.2 Lung Cancer Screening
    • 1.5.3 Breast Cancer Screening
    • 1.5.4 Prostate Cancer Screening
    • 1.5.5 Colorectal Cancer Screening
    • 1.5.6 Blood Cancer Screening
    • 1.5.7 Liver Cancer Screening
    • 1.5.8 Pancreatic Cancer Screening
    • 1.5.9 Skin Cancer Screening
    • 1.5.10 Cervical Cancer Screening
    • 1.5.11 Other
  • 1.6 Coronavirus Disease 2019 (Covid-19): Cancer Screening Technology Industry Impact
    • 1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.6.2 Covid-19 Impact: Commodity Prices Indices
    • 1.6.3 Covid-19 Impact: Global Major Government Policy
  • 1.7 Study Objectives
  • 1.8 Years Considered

2 Global Growth Trends

  • 2.1 Covid-19 Implications on Global Cancer Screening Technology Market Perspective (2015-2026)
  • 2.2 Covid-19 Implications on Global Cancer Screening Technology Growth Trends by Regions
    • 2.2.1 Cancer Screening Technology Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Cancer Screening Technology Historic Market Share by Regions (2015-2020)
    • 2.2.3 Cancer Screening Technology Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Top Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Porter’s Five Forces Analysis
    • 2.3.5 Cancer Screening Technology Market Growth Strategy
    • 2.3.6 Primary Interviews with Key Cancer Screening Technology Players (Opinion Leaders)

3 Covid-19 Implications on Competition Landscape by Key Players

  • 3.1 Global Top Cancer Screening Technology Players by Market Size
    • 3.1.1 Global Top Cancer Screening Technology Players by Revenue (2015-2020)
    • 3.1.2 Global Cancer Screening Technology Revenue Market Share by Players (2015-2020)
    • 3.1.3 Global Cancer Screening Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.2 Global Cancer Screening Technology Market Concentration Ratio
    • 3.2.1 Global Cancer Screening Technology Market Concentration Ratio (CR5 and HHI)
    • 3.2.2 Global Top 10 and Top 5 Companies by Cancer Screening Technology Revenue in 2019
  • 3.3 Cancer Screening Technology Key Players Head office and Area Served
  • 3.4 Key Players Cancer Screening Technology Product Solution and Service
  • 3.5 Date of Enter into Cancer Screening Technology Market
  • 3.6 Mergers & Acquisitions, Expansion Plans

4 Covid-19 Implications on Market Size by Type (2015-2026)

  • 4.1 Global Cancer Screening Technology Historic Market Size by Type (2015-2020)
  • 4.2 Global Cancer Screening Technology Forecasted Market Size by Type (2021-2026)

5 Covid-19 Implications on Market Size by Application (2015-2026)

  • 5.1 Global Cancer Screening Technology Market Size by Application (2015-2020)
  • 5.2 Global Cancer Screening Technology Forecasted Market Size by Application (2021-2026)

6 North America Impact of COVID-19

  • 6.1 North America Cancer Screening Technology Market Size (2015-2020)
  • 6.2 Cancer Screening Technology Key Players in North America (2019-2020)
  • 6.3 North America Cancer Screening Technology Market Size by Type (2015-2020)
  • 6.4 North America Cancer Screening Technology Market Size by Application (2015-2020)

7 Europe Impact of COVID-19

  • 7.1 Europe Cancer Screening Technology Market Size (2015-2020)
  • 7.2 Cancer Screening Technology Key Players in Europe (2019-2020)
  • 7.3 Europe Cancer Screening Technology Market Size by Type (2015-2020)
  • 7.4 Europe Cancer Screening Technology Market Size by Application (2015-2020)

8 China Impact of COVID-19

  • 8.1 China Cancer Screening Technology Market Size (2015-2020)
  • 8.2 Cancer Screening Technology Key Players in China (2019-2020)
  • 8.3 China Cancer Screening Technology Market Size by Type (2015-2020)
  • 8.4 China Cancer Screening Technology Market Size by Application (2015-2020)

9 Japan Impact of COVID-19

  • 9.1 Japan Cancer Screening Technology Market Size (2015-2020)
  • 9.2 Cancer Screening Technology Key Players in Japan (2019-2020)
  • 9.3 Japan Cancer Screening Technology Market Size by Type (2015-2020)
  • 9.4 Japan Cancer Screening Technology Market Size by Application (2015-2020)

10 Southeast Asia Impact of COVID-19

  • 10.1 Southeast Asia Cancer Screening Technology Market Size (2015-2020)
  • 10.2 Cancer Screening Technology Key Players in Southeast Asia (2019-2020)
  • 10.3 Southeast Asia Cancer Screening Technology Market Size by Type (2015-2020)
  • 10.4 Southeast Asia Cancer Screening Technology Market Size by Application (2015-2020)

11 India Impact of COVID-19

  • 11.1 India Cancer Screening Technology Market Size (2015-2020)
  • 11.2 Cancer Screening Technology Key Players in India (2019-2020)
  • 11.3 India Cancer Screening Technology Market Size by Type (2015-2020)
  • 11.4 India Cancer Screening Technology Market Size by Application (2015-2020)

12 Central & South America Impact of COVID-19

  • 12.1 Central & South America Cancer Screening Technology Market Size (2015-2020)
  • 12.2 Cancer Screening Technology Key Players in Central & South America (2019-2020)
  • 12.3 Central & South America Cancer Screening Technology Market Size by Type (2015-2020)
  • 12.4 Central & South America Cancer Screening Technology Market Size by Application (2015-2020)

13Key Players Profiles

  • 13.1 Abbott
    • 13.1.1 Abbott Company Details
    • 13.1.2 Abbott Business Overview and Its Total Revenue
    • 13.1.3 Abbott Cancer Screening Technology Introduction
    • 13.1.4 Abbott Revenue in Cancer Screening Technology Business (2015-2020))
    • 13.1.5 Abbott Recent Development and Reaction to COVID-19
  • 13.2 BD
    • 13.2.1 BD Company Details
    • 13.2.2 BD Business Overview and Its Total Revenue
    • 13.2.3 BD Cancer Screening Technology Introduction
    • 13.2.4 BD Revenue in Cancer Screening Technology Business (2015-2020)
    • 13.2.5 BD Recent Development and Reaction to COVID-19
  • 13.3 Siemens Healthineers
    • 13.3.1 Siemens Healthineers Company Details
    • 13.3.2 Siemens Healthineers Business Overview and Its Total Revenue
    • 13.3.3 Siemens Healthineers Cancer Screening Technology Introduction
    • 13.3.4 Siemens Healthineers Revenue in Cancer Screening Technology Business (2015-2020)
    • 13.3.5 Siemens Healthineers Recent Development and Reaction to COVID-19
  • 13.4 GE Healthcare
    • 13.4.1 GE Healthcare Company Details
    • 13.4.2 GE Healthcare Business Overview and Its Total Revenue
    • 13.4.3 GE Healthcare Cancer Screening Technology Introduction
    • 13.4.4 GE Healthcare Revenue in Cancer Screening Technology Business (2015-2020)
    • 13.4.5 GE Healthcare Recent Development and Reaction to COVID-19
  • 13.5 F. Hoffmann-La Roche
    • 13.5.1 F. Hoffmann-La Roche Company Details
    • 13.5.2 F. Hoffmann-La Roche Business Overview and Its Total Revenue
    • 13.5.3 F. Hoffmann-La Roche Cancer Screening Technology Introduction
    • 13.5.4 F. Hoffmann-La Roche Revenue in Cancer Screening Technology Business (2015-2020)
    • 13.5.5 F. Hoffmann-La Roche Recent Development and Reaction to COVID-19
  • 13.6 Olympus Corporation
    • 13.6.1 Olympus Corporation Company Details
    • 13.6.2 Olympus Corporation Business Overview and Its Total Revenue
    • 13.6.3 Olympus Corporation Cancer Screening Technology Introduction
    • 13.6.4 Olympus Corporation Revenue in Cancer Screening Technology Business (2015-2020)
    • 13.6.5 Olympus Corporation Recent Development and Reaction to COVID-19
  • 13.7 FUJIFILM Corporation
    • 13.7.1 FUJIFILM Corporation Company Details
    • 13.7.2 FUJIFILM Corporation Business Overview and Its Total Revenue
    • 13.7.3 FUJIFILM Corporation Cancer Screening Technology Introduction
    • 13.7.4 FUJIFILM Corporation Revenue in Cancer Screening Technology Business (2015-2020)
    • 13.7.5 FUJIFILM Corporation Recent Development and Reaction to COVID-19
  • 13.8 Agilent Technologies
    • 13.8.1 Agilent Technologies Company Details
    • 13.8.2 Agilent Technologies Business Overview and Its Total Revenue
    • 13.8.3 Agilent Technologies Cancer Screening Technology Introduction
    • 13.8.4 Agilent Technologies Revenue in Cancer Screening Technology Business (2015-2020)
    • 13.8.5 Agilent Technologies Recent Development and Reaction to COVID-19
  • 13.9 Eiken Chemical
    • 13.9.1 Eiken Chemical Company Details
    • 13.9.2 Eiken Chemical Business Overview and Its Total Revenue
    • 13.9.3 Eiken Chemical Cancer Screening Technology Introduction
    • 13.9.4 Eiken Chemical Revenue in Cancer Screening Technology Business (2015-2020)
    • 13.9.5 Eiken Chemical Recent Development and Reaction to COVID-19
  • 13.10 Hitachi Chemical (Kyowa Medex)
    • 13.10.1 Hitachi Chemical (Kyowa Medex) Company Details
    • 13.10.2 Hitachi Chemical (Kyowa Medex) Business Overview and Its Total Revenue
    • 13.10.3 Hitachi Chemical (Kyowa Medex) Cancer Screening Technology Introduction
    • 13.10.4 Hitachi Chemical (Kyowa Medex) Revenue in Cancer Screening Technology Business (2015-2020)
    • 13.10.5 Hitachi Chemical (Kyowa Medex) Recent Development and Reaction to COVID-19
  • 13.11 Clinical Genomics Pty Ltd (Quest Diagnostics)
    • 10.11.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Company Details
    • 10.11.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview and Its Total Revenue
    • 10.11.3 Clinical Genomics Pty Ltd (Quest Diagnostics) Cancer Screening Technology Introduction
    • 10.11.4 Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in Cancer Screening Technology Business (2015-2020)
    • 10.11.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Development and Reaction to COVID-19
  • 13.12 Sysmex
    • 10.12.1 Sysmex Company Details
    • 10.12.2 Sysmex Business Overview and Its Total Revenue
    • 10.12.3 Sysmex Cancer Screening Technology Introduction
    • 10.12.4 Sysmex Revenue in Cancer Screening Technology Business (2015-2020)
    • 10.12.5 Sysmex Recent Development and Reaction to COVID-19
  • 13.13 QIAGEN
    • 10.13.1 QIAGEN Company Details
    • 10.13.2 QIAGEN Business Overview and Its Total Revenue
    • 10.13.3 QIAGEN Cancer Screening Technology Introduction
    • 10.13.4 QIAGEN Revenue in Cancer Screening Technology Business (2015-2020)
    • 10.13.5 QIAGEN Recent Development and Reaction to COVID-19
  • 13.14 R-Biopharm
    • 10.14.1 R-Biopharm Company Details
    • 10.14.2 R-Biopharm Business Overview and Its Total Revenue
    • 10.14.3 R-Biopharm Cancer Screening Technology Introduction
    • 10.14.4 R-Biopharm Revenue in Cancer Screening Technology Business (2015-2020)
    • 10.14.5 R-Biopharm Recent Development and Reaction to COVID-19
  • 13.15 Immunostics
    • 10.15.1 Immunostics Company Details
    • 10.15.2 Immunostics Business Overview and Its Total Revenue
    • 10.15.3 Immunostics Cancer Screening Technology Introduction
    • 10.15.4 Immunostics Revenue in Cancer Screening Technology Business (2015-2020)
    • 10.15.5 Immunostics Recent Development and Reaction to COVID-19

14Analyst's Viewpoints/Conclusions

    15Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Disclaimer

    Cancer Screening Technology market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Cancer Screening Technology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
    Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Cancer Screening Technology market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
    This report also analyzes the impact of Coronavirus COVID-19 on the Cancer Screening Technology industry.

    The key players covered in this study
    Abbott
    BD
    Siemens Healthineers
    GE Healthcare
    F. Hoffmann-La Roche
    Olympus Corporation
    FUJIFILM Corporation
    Agilent Technologies
    Eiken Chemical
    Hitachi Chemical (Kyowa Medex)
    Clinical Genomics Pty Ltd (Quest Diagnostics)
    Sysmex
    QIAGEN
    R-Biopharm
    Immunostics

    Market segment by Type, the product can be split into
    Instrument-based Inspection
    Platform-based Inspection
    Market segment by Application, split into
    Lung Cancer Screening
    Breast Cancer Screening
    Prostate Cancer Screening
    Colorectal Cancer Screening
    Blood Cancer Screening
    Liver Cancer Screening
    Pancreatic Cancer Screening
    Skin Cancer Screening
    Cervical Cancer Screening

    Market segment by Regions/Countries, this report covers
    North America
    Europe
    China
    Japan
    Southeast Asia
    India
    Central & South America

    The study objectives of this report are:
    To analyze global Cancer Screening Technology status, future forecast, growth opportunity, key market and key players.
    To present the Cancer Screening Technology development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
    To strategically profile the key players and comprehensively analyze their development plan and strategies.
    To define, describe and forecast the market by type, market and key regions.

    In this study, the years considered to estimate the market size of Cancer Screening Technology are as follows:
    History Year: 2015-2019
    Base Year: 2019
    Estimated Year: 2020
    Forecast Year 2020 to 2026
    For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
    Buy now